Failure of intravenously administered immunoglobulin in the treatment of neonatal myasthenia gravis

Journal of Pediatrics

Volumn 134, Issue 2, 1999, Pages 233-235

  Tagher, Robert J ^a,b,c   Baumann, Robert ^a,b   Desai, Nirmala ^a,b  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; NEOSTIGMINE;

ARTICLE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MYASTHENIA GRAVIS; NEWBORN; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032987781     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70422-1     Document Type: Article

References (16)

1. 1. Gajdos PH, Outin HD, Morel E, Raphail JC, Goulon, M. High-dose intravenous gamma globulin for myasthenia gravis: an alternative to plasma exchange? Ann N Y Acad Sci 1987; 505:828-31.
2. 2. Strickroot FL, Schaeffer RL, Bergo HL. Myasthenia gravis occurring in an infant born of a myasthenic mother. JAMA 1942;120:1207-9.
3. 3. Namba T, Stuart BB, Grob D. Neonatal myasthenia gravis: report of two cases and review of the literature. Pediatrics 1970;45:488-504.
4. 4. Garabedian BV, Eymard B, Bach JF, Morel E. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity. J Neuroimmunol 1989;21:41-7.
5. 5. Nigro MA. Myasthenia gravis in infancy and childhood. In: Lisak RP, editor. Handbook of myasthenia gravis and myasthenic syndromes. New York: Dekker; 1994. p. 63-79.
6. 6. Papazian O. Transient neonatal myasthenia gravis. J Child Neurol 1992;7: 135-41.
7. 7. Volpe JJ. Neurology of the newborn. Philadelphia: WB Saunders; 1995. p. 621-6.
8. 8. Lefvert AK, Osterman PO. Newborn infants to myasthenic mothers: a clinical study and an investigation of acetylcholine receptor antibodies in 17 children. Neurology 1983;33:133-8.
9. 9. Bartoccioni E, Evoli A, Casali C, Scopetta C, Tonali P, Provenzano C. Neonatal myasthenia gravis: clinical and immunological study of seven mothers and their newborn infants. J Neuroimmunol 1986;12:155-61.
10. 10. Lefvert AK, Bergstrom K, Matell G, Osterman PO, Pirskanen R. Determination of acetylcholine receptor antibody in myasthenia gravis: clinical usefulness and pathogenetic implications. J Neurol Neurosurg Psychiatry 1978;41:394-403.
11. 11. Keesey J, Lindstom J, Cokely H. Anti-acetylcholine receptor antibody in neonatal myasthenia gravis [letter]. N Engl J Med 1977;296:55.
12. 12. Donaldson JO, Penn AS, Lisak RP, Oded A, Brenner T, Schotland DL. Anti-acetylcholine receptor antibody in neonatal myasthenia gravis. Am J Dis Child 1981;125:222-6.
13. 13. Morel E, Eymard B, Vernet der Garabedian B, Pannier C, Dulac O, Bach JF. Neonatal myasthenia gravis: a new clinical and immunologic appraisal of 30 cases. Neurology 1988;38:138-42.
14. 14. Pasternak JF, Hageman J, Adams MA, Philip AGS, Gardner TH. Exchange transfusion in neonatal myasthenia. J Pediatr 1981;99:644-6.
15. 15. Donat JF, Donat JR, Lennon VA. Exchange transfusion in neonatal myasthenia gravis. Neurology 1981;31: 911-2.
16. 16. Johnson RT, Griffin, JW. Current therapy in neurologic disease. 5th ed. St Louis: Mosby; 1997. p. 392-400.